News on Iontophoresis from BioPortfolio.com http://www.BioPortfolio.com Consolidated Iontophoresis news from BioPortfolio.com Tue, 09 Feb 2010 22:34:45 GMT en Iontophoresis in the approach to patients with chronic painhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024171&HITNO=0&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024171&THISHREF=http://c.moreover.com/click/here.pl%3fz2528676638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024171&HITNO=0&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024171&THISHREF=http://c.moreover.com/click/here.pl%3fz2528676638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Research on eye research detailed by scientists at University of Cincinnatihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956292&HITNO=1&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956292&THISHREF=http://c.moreover.com/click/here.pl%3fz2494482664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956292&HITNO=1&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956292&THISHREF=http://c.moreover.com/click/here.pl%3fz2494482664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883599&HITNO=2&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883599&THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883599&HITNO=2&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883599&THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883471&HITNO=3&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883471&THISHREF=http://c.moreover.com/click/here.pl%3fz2455750635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883471&HITNO=3&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883471&THISHREF=http://c.moreover.com/click/here.pl%3fz2455750635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880091&HITNO=4&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880091&THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880091&HITNO=4&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880091&THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880052&HITNO=5&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880052&THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880052&HITNO=5&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880052&THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: ::: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879468&HITNO=6&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879468&THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879468&HITNO=6&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879468&THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: EyeGate Pharma Secures $http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878058&HITNO=7&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878058&THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878058&HITNO=7&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878058&THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: EyeGate Pharma Raises $22.6 Millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877696&HITNO=8&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877696&THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877696&HITNO=8&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877696&THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPrivate Equity HUB: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876619&HITNO=9&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876619&THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876619&HITNO=9&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876619&THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876587&HITNO=10&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876587&THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876587&HITNO=10&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876587&THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876509&HITNO=11&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876509&THISHREF=http://c.moreover.com/click/here.pl%3fz2451547377%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876509&HITNO=11&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876509&THISHREF=http://c.moreover.com/click/here.pl%3fz2451547377%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876433&HITNO=12&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876433&THISHREF=http://c.moreover.com/click/here.pl%3fz2451530039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876433&HITNO=12&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876433&THISHREF=http://c.moreover.com/click/here.pl%3fz2451530039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876425&HITNO=13&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876425&THISHREF=http://c.moreover.com/click/here.pl%3fz2451527163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876425&HITNO=13&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876425&THISHREF=http://c.moreover.com/click/here.pl%3fz2451527163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876424&HITNO=14&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876424&THISHREF=http://c.moreover.com/click/here.pl%3fz2451523684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3876424&HITNO=14&MSIZE=16&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Iontophoresis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3876424&THISHREF=http://c.moreover.com/click/here.pl%3fz2451523684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: